Spectrum Pharmaceuticals Announces Completion Of Enrollment In One …
Spectrum Pharmaceuticals (NasdaqGM: SPPI) today announced that one of the two Phase 3 pivotal clinical trials of apaziquone has achieved its enrollment target,
Continued here:
Spectrum Pharmaceuticals Announces Completion Of Enrollment In One …